Oral lichenoid drug eruption: A report of a pediatric case and review of the literature

Pediatric Dermatology

Volumn 26, Issue 4, 2009, Pages 458-464

  Woo, Victoria ^a,b   Bonks, Julia ^c   Borukhova, Lyubov ^c   Zegarelli, David ^c  

^a Division of Oral Pathology ^*  (United States)

^b UNIVERSITY OF NEVADA   (United States)

^c Columbia University College of Dental Medicine ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; DEXAMETHASONE; MOUTHWASH; RISPERIDONE;

ADOLESCENT; ARTICLE; BIOPSY; CASE REPORT; CHEEK MUCOSA; CLINICAL EVALUATION; CONSULTATION; DISEASE DURATION; DRUG ERUPTION; DRUG WITHDRAWAL; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERKERATOSIS; INSOMNIA; LICHEN PLANUS; MALE; MOOD DISORDER; MOUTH EXAMINATION; MUCOSA INFLAMMATION; ONSET AGE; ORAL LICHENOID DRUG ERUPTION; PRIORITY JOURNAL; TREATMENT DURATION;

ADOLESCENT; ANTIPSYCHOTIC AGENTS; DIETHYLCARBAMAZINE; DRUG ERUPTIONS; HUMANS; LICHEN PLANUS; MALE; MOOD DISORDERS; MOUTH DISEASES; MOUTH MUCOSA; RISPERIDONE; SLEEP INITIATION AND MAINTENANCE DISORDERS; TONGUE;

EID: 68849117217     PISSN: 07368046     EISSN: 15251470     Source Type: Journal    
DOI: 10.1111/j.1525-1470.2009.00953.x     Document Type: Article

References (66)

1. Boyd AS, King LE. Lichenoid drug reaction from isotretinoin therapy. Cutis 2001 68 : 301 303.
2. Kaur S, Bhalla M, Thami GP. Subacute lichenoid eruption due to L-thyroxine overdosage. Dermatology 2003 206 : 346 347.
3. Scully C, Bagan JV. Adverse drug reactions in the orofacial region. Crit Rev Oral Biol Med 2004 15 : 221 239.
4. Korstanje MJ. Drug-induced mouth disorders. Clin Exp Dermatol 1995 20 : 10 18.
5. McCartan BE, McCreary CE. Oral lichenoid drug eruptions. Oral Dis 1997 3 : 58 63.
6. Günes AT, Fetil E, Ilknur T et al. Naproxen-induced lichen planus: report of 55 cases. Int J Dermatol 2006 45 : 709 712.
7. Tilly JJ, Drolet BA, Esterly NB. Lichenoid eruptions in children. J Am Acad Dermatol 2004 51 : 606 624.
8. Neville BW, Damm DD, Allen CM et al. Allergies and immunologic diseases. In : Neville BW, Damm DD, Allen CM, Bouquot JE, eds. Oral & maxillofacial pathology, 2nd edn. New York : W.B. Saunders Company, 2002 : 300 303.
9. Hay KD, Reade PC. Methyldopa as a cause of oral mucous membrane reactions. Br Dent J 1978 145 : 195 203.
10. Wiesenfeld D, Scully C, MacFadyen EE. Multiple lichenoid drug reactions in patients with Ferguson-Smith disease. Oral Surg Oral Med Oral Pathol 1982 54 : 527 529.
11. Lamey PJ, McCartan BE, MacDonald DG et al. Basal cell cytoplasmic autoantibodies in oral lichenoid reactions. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1995 79 : 44 49.
12. Robinson NA. Lichenoid tissue reactions of the oral mucosa. Singapore Dent J 2000 23 (Suppl. 1 56 63.
13. Campisi G, Florena AM, Franco V et al. Oral lichenoid drug reaction by lithium in a patient with bipolar disorder. J Oral Pathol Med 2005 34 : 124 126.
14. Potts AJ, Hamburger J, Scully C. The medication of patients with oral lichen planus and the association of nonsteroidal anti-inflammatory drugs with erosive lesions. Oral Surg Oral Med Oral Pathol 1987 64 : 541 543.
15. Van den Haute V, Antoine JL, Lachapelle JM. Histopathological discriminant criteria between lichenoid drug eruption and idiopathic lichen planus: retrospective study on selected samples. Dermatologica 1989 179 : 10 13.
16. Halevy S, Shai A. Lichenoid drug eruptions. J Am Acad Dermatol 1993 29 (2 pt 1 249 255.
17. McCartan BE, McCreary CE, Healy CM. Studies of drug-induced lichenoid reactions: criteria for case selection. Oral Dis 2003 9 : 163 164.
18. Zelickson BD, Rogers RS III. Drug reactions involving the mouth. Clin Dermatol 1986 4 : 98 109.
19. Van Beek MJ, Piette WW. Antimalarials. Dermatol Clin 2001 19 : 147 160.
20. Hawk JLM. Lichenoid drug eruption induced by propanolol. Clin Exp Dermatol 1980 5 : 93 96.
21. Robertson WD, Wray D. Ingestion of medication among patients with oral keratoses including lichen planus. Oral Surg Oral Med Oral Pathol 1992 74 : 183 185.
22. Breathnach S. Drug reactions. In : Burns T, Breathnach S, Cox N, Griffiths C, eds. Rook's textbook of dermatology, Vol. 4, 7th edn. Oxford : Blackwell Science, 2004 : 1 180.
23. Firth NA, Reade PC. Angiotensin-converting enzyme inhibitors implicated in oral mucosal lichenoid reactions. Oral Surg Oral Med Oral Pathol 1989 67 : 41 44.
24. Hamburger J, Potts AJ. Non-steroidal anti-inflammatory drugs and oral lichenoid reactions. Br Med J (Clin Res Ed) 1983 287 : 1258.
25. Bagán JV, Thongprasom K, Scully C. Adverse oral reactions associated with the COX-2 inhibitor rofecoxib. Oral Dis 2004 10 : 401 403.
26. Scully C, Diz Dios P. Orofacial effects of antiretroviral therapies. Oral Dis 2001 7 : 205 210.
27. Ficarra G, Flaitz CM, Gaglioti D et al. White lichenoid lesions of the buccal mucosa in patients with HIV infection. Oral Surg Oral Med Oral Pathol 1993 76 : 460 466.
28. Büyükgebiz B, Arslan N, Ostürk Y et al. Drug reaction to ursodeoxycholic acid: lichenoid drug eruption in an infant using ursodeoxycholic acid for neonatal hepatitis. J Pediatr Gastroenterol Nutr 2002 35 : 384 386.
29. Ridola V, Mahé E, Fawaz O et al. Dactinomycin-induced severe lichenoid eruption in a child. Pediatr Dermatol 2006 23 : 503 506.
30. Kanwar VS, Gajjar A, Ribeiro RC et al. Unusual cutaneous toxicity following treatment with dactinomycin: a report of two cases. Med Pediatr Oncol 1995 24 : 329 333.
31. Parks ET. Lesions associated with drug reactions. Dermatol Clin 1996 14 : 327 337.
32. Wright JM. Oral manifestations of drug reactions. Dent Clin North Am 1984 28 : 529 543.
33. Tack DA, Rogers RS. Oral drug reactions. Dermatol Ther 2002 15 : 236 250.
34. Pua VS, Scolyer RA, Barnetson RS. Pravastatin-induced lichenoid drug eruption. Australas J Dermatol 2006 47 : 57 59.
35. Ellgehausen P, Elsner P, Burg G. Drug-induced lichen planus. Clin Dermatol 1998 16 : 325 332.
36. Al-Hashimi I, Schifter M, Lockhart PB et al. Oral lichen planus and oral lichenoid lesions: diagnostic and therapeutic considerations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007 103 (Suppl. 1 S25 S31.
37. Felder RS, Millar SB, Henry RH. Oral manifestations of drug therapy. Spec Care Dentist 1988 8 : 119 124.
38. Usman A, Kimyai-Asadi A, Stiller MJ et al. Lichenoid eruption following hepatitis B vaccination: first North American case report. Pediatr Dermatol 2001 18 : 123 126.
39. Agrawal S, Garg VK, Joshi A et al. Lichen planus after HBV vaccination in a child: a case report from Nepal. J Dermatol 2000 27 : 618 620.
40. Limas C, Limas CJ. Lichen planus in children: a possible complication of hepatitis B vaccines. Pediatr Dermatol 2002 19 : 204 209.
41. Cottoni F, Ena P, Tedde G et al. Lichen planus in children: a case report. Pediatr Dermatol 1993 10 : 132 135.
42. Kanwar AJ, Handa S, Ghosh S et al. Lichen planus in childhood: a report of 17 patients. Pediatr Dermatol 1991 8 : 288 291.
43. Kumar V, Garg BR, Baruah MC et al. Childhood lichen planus (LP). J Dermatol 1993 20 : 175 177.
44. Sharma R, Maheshwari V. Childhood lichen planus: a report of fifty cases. Pediatr Dermatol 1999 16 : 345 348.
45. Nanda A, Al-Ajmi HS, Al-Sabah H et al. Childhood lichen planus: a report of 23 cases. Pediatr Dermatol 2001 18 : 1 4.
46. Alam F, Hamburger J. Oral mucosal lichen planus in children. Int J Paediatr Dent 2001 11 : 209 214.
47. Winer LH, Leeb AJ. Lichenoid eruptions. a histopathological study. AMA Arch Derm Syphilol 1954 70 : 274 281.
48. Beckman KA, Chanes L, Kaufman SR. Lichen planus associated with topical beta-blocker therapy. Am J Opthalmol 1995 120 : 530 531.
49. Powell ML, Ehrlich A, Belsito DV. Lichenoid drug eruption to salsalate. J Am Acad Dermatol 2001 45 : 616 619.
50. Schiødt M. Oral lupus erythematosus. III. A histopathologic study of sixty-six patients. Oral Surg Oral Med Oral Pathol 1984 57 : 281 293.
51. Helander SD, Rogers RS III. The sensitivity and specificity of direct immunofluorescence testing in disorders of mucous membranes. J Am Acad Dermatol 1994 30 : 65 75.
52. Van Joost T. Incidence of circulating antibodies reactive with basal cells of skin in drug reactions. Acta Derm Venereol Suppl (Stockh) 1974 54 : 183 187.
53. McQueen A, Behan WMH. The 'string of pearls' phenomenon - an immunofluorescent serological finding in patients screened for adverse drug reactions. Am J Dermatopathol 1982 4 : 155 159.
54. Kurumaji Y, Miyazaki K. Tiopronin-induced lichenoid eruption in a patient with liver disease and positive patch test reaction to drugs with sulfhydryl group. J Dermatol 1990 17 : 176 181.
55. Sharma VK, Vatve M, Sawhney IM et al. Clinical spectrum of drug rashes due to antiepileptics. J Assoc Physicians India 1998 46 : 595 597.
56. Penneys NS, Ackerman AB, Gottlieb NL. Gold dermatitis. Arch Dermatol 1974 109 : 372 376.
57. Savage NW. Oral lichenoid drug eruptions. Oral Dis 1997 3 : 55 57.
58. Lozada-Nur FI, Sroussi HY. Tacrolimus powder in Orabase 0.1% for the treatment of oral lichen planus and oral lichenoid lesions: an open clinical trial. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006 102 : 744 749.
59. Dalmau J, Peramiquel L, Puig L et al. Imatinib-associated lichenoid eruption: acitretin treatment allows maintained antineoplastic effect. Br J Dermatol 2006 154 : 1213 1216.
60. Thomson Healthcare, Inc. Physician's desk reference, 59th ed. New Jersey : Thomson Healthcare, Inc., 2005. p. 1742 1747, 2377-2380.
61. Roberts DL, Marks R. Skin reactions to carbamazepine. Arch Dermatol 1981 117 : 273 275.
62. Atkin SL, Mckenzie TM, Stevenson CJ. Carbamazepine-induced lichenoid eruption. Clin Exp Dermatol 1990 15 : 382 383.
63. Jain KK. Systemic lupus erythematosus (SLE)-like syndromes associated with carbamazepine therapy. Drug Saf 1991 6 : 350 360.
64. Simpson JR. "Collagen disease" due to carbamazepine (Tegretol). Br Med J 1966 2 : 1434.
65. Shuttleworth D, Graham-Brown RA. Fixed drug eruption due to carbamazepine. Clin Exp Dermatol 1984 9 : 424 426.
66. Goldstein S. Is ADHD a growth industry. J Atten Disord 2006 9 : 461 464.